U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605728) titled 'Probiotics for Abemaciclib-Induced Abdominal Discomfort.' on May 11.
Brief Summary: This study aims to evaluate whether the addition of probiotics can help reduce abdominal discomfort (such as diarrhea) in breast cancer patients receiving Abemaciclib treatment. Abemaciclib is an effective targeted therapy but often causes gastrointestinal side effects. While Loperamide is the standard treatment for diarrhea, this study explores if probiotics can provide additional relief and improve metabolic health.Participants will be randomly assigned to receive either probiotics or a placebo alongside their standard care. The study will monitor t...